COVID-19

      vaccine.jpg
      Rituximab Patients May Benefit from Third COVID-19 Vaccine Dose
      • ACR
      3 years 5 months ago
      New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows immunocompromised patients using rituximab (a drug used to treat diseases like…

      Podcasts

      • Osteoarthritis Risky Business (4.18.2025)
      • EMR Messaging Woes (4.11.2025)
      • An Epidural Letdown (4.4.2025)

      Catch up on Conference Podcasts

      ×